Our findings are in agreement with recent reports revealing that suppression of the FoxM1/Mcl-1 pathway impairs cell viability and thus increases sensitivity to CDDP in GC cells (Li et al., 2016). This evidence concerns the gene FOXM1 and gastric cancer.